(August 25, 2023, 1:25 PM EDT) -- AUSTIN, Texas — Price restrictions on Medicare drugs strip away various constitutional protections and will harm competition from biosimilars even when the caps are not applied to drugs with biosimilar competitors, an advocacy group tells a federal judge in Texas in an Aug. 24 amicus curiae brief....